1042. Safety of Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Individuals with Recurrent Clostridioides difficile Infection: Data from Five Prospective Clinical Studies

BACKGROUND: Microbiota-based treatments have shown promise to reduce recurrence, morbidity, and mortality for recurrent Clostridioides difficile infections (rCDI), but consistent and reliable safety data are needed to support regulatory approvals and broaden patient access. Here we provide cumulativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Tricia, Guthmueller, Beth, Harvey, Adam J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644482/
http://dx.doi.org/10.1093/ofid/ofab466.1236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644482/
http://dx.doi.org/10.1093/ofid/ofab466.1236

Ejemplares similares